Literature DB >> 10388331

[Levofloxacin-induced neurological adverse effects such as convulsion, involuntary movement (tremor, myoclonus and chorea like), visual hallucination in two elderly patients].

H Yasuda1, A Yoshida, Y Masuda, M Fukayama, Y Kita, T Inamatsu.   

Abstract

Levofloxacin-induced-neurological adverse events such as convulsion, involuntary movement (tremor, myoclonus and chorea-like) and visual hallucination in two elderly patients are reported. A 67-year-old man with minor alcoholism and a past-history of gastrectomy and cholecystectomy was given 300 mg/day of oral levofloxacin and fulfenamic acid for an upper respiratory infection. On the 4th day, he reported gradual exacerbation of hand tremor which resembled chorea-like involuntary movement and gait disturbance. He also experienced visual hallucinations. On the 7th day, he suffered generalized convulsions and was admitted. Serum concentration of levofloxacin at this time (3 hours after last administration of a 100 mg tablet of levofloxacin) was 3.6 micrograms/ml. Cessation of the agents promoted complete recovery of these neurological adverse effects within a week. Another 85-year-old man with chronic bronchitis and slight renal impairment received long term administration of 200 mg/day of levofloxacin. On the 68th day of administration, gradual exacerbation of gait disturbance, dysarthria and chorea-like involuntary movement occurred. On the day of admission, 76 days after the start of administration, the serum level of levofloxacin was 2.55 micrograms/ml and that of spinal fluid was 1.12 micrograms/ml (3 hours after the last administration of a 100 mg tablet of levofloxacin). Cessation of the agents promoted complete recovery of these neurological adverse effects within the next two weeks. Both patients had no apparent neurological disorders except age-related brain atrophy. Age-related renal and brain impairment might have contributed to the neurological adverse effects of levofloxacin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10388331     DOI: 10.3143/geriatrics.36.213

Source DB:  PubMed          Journal:  Nihon Ronen Igakkai Zasshi        ISSN: 0300-9173


  8 in total

1.  Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.

Authors:  Beatrice Alexandra Golomb; Hayley Jean Koslik; Alan J Redd
Journal:  BMJ Case Rep       Date:  2015-10-05

Review 2.  A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.

Authors:  S J Martin; R Jung; C G Garvin
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  A seizure attributed to ofloxacine in a woman undergoing detoxification for alcohol dependence.

Authors:  Pierre Lahmek; Laurent Michel; Nadine Meunier; Henri-Jean Aubin
Journal:  Case Rep Med       Date:  2010-01-24

Review 4.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  A Rare Instance of Levofloxacin Induced Myoclonus.

Authors:  Sushil Kiran Kunder; A Avinash; Veena Nayak; Amod Tilak
Journal:  J Clin Diagn Res       Date:  2017-07-01

6.  Reversible craniocervical dystonia associated with levofloxacin.

Authors:  Karlo J Lizarraga; Maria R Lopez; Carlos Singer
Journal:  J Clin Mov Disord       Date:  2015-05-04

7.  Levofloxacin-associated Encephalopathy with Severe Hyperventilation.

Authors:  Mieko Sugiura; Koichi Shibata; Satoshi Saito; Yoshiko Nishimura; Hiroshi Sakura
Journal:  Intern Med       Date:  2019-02-01       Impact factor: 1.271

8.  Levofloxacin-induced tactile hallucination and acute anxiety reaction.

Authors:  B Maharani; A Lourdu Jafrin; K Vyshnavi Bai; G Sivagnanam
Journal:  Indian J Pharmacol       Date:  2019 Mar-Apr       Impact factor: 1.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.